Geology topics

William H. Gingerich

Publications and source records attributed to William H. Gingerich.

10 recordsLinked to original sources

USGS2020

Determination of benzocaine in rainbow trout plasma

A liquid chromatographic method is described for analysis of benzocaine (BZ), a proposed fish anesthetic, in rainbow trout plasma. Mean recoveries of BZ from plasma samples fortified at 44–10 100 ng/mL were 96–100%. The method detection limit is 10 ng/mL, and the limit of quantitation is 37 ng/mL. Acetylation of BZ occurs in whole blood after storage at room temperature (i.e., 21 °C) for 10 min. However, no acetylation of BZ was detected in plasma samples held at room temperature for 4 h. Mean method precision for plasma samples with incurred BZ residue is similar to that for fortified samples in the same concentration range (relative standard deviations of 0.9 and 1.2%, respectively).

Journal of AOAC International↗

USGS2006

Isoeugenol concentrations in rainbow trout (Oncorhynchus mykiss) skin-on fillet tissue after exposure to AQUI-S™ at different temperatures, durations, and concentrations

AQUI-S™ is a fish anesthetic/sedative approved for use in several countries including Australia, Chile, and New Zealand and is being pursued for use in the United States. Legal use of AQUI-S™ as an anesthetic in U.S. fish culture depends on approval by the U.S. Food and Drug Administration (FDA). To gain approval in the United States, a number of drug attributes must be characterized including (1) depletion of a drug's total residues from edible fillet tissue taken from exposed fish and (2) depletion of one primary drug residue (a marker residue) from the fillet tissue. The marker residue is selected on the basis of data generated during the total residue depletion study. Characterizing marker residue depletion allows the FDA to establish a withdrawal time for exposed fish ensuring total residue concentrations reach safe levels before fish are made available for human consumption in the U.S. Before an AQUI-S™ total residue depletion study could be conducted with rainbow trout ( Oncorhynchus mykiss ), the exposure parameters (water temperature, isoeugenol concentration, and exposure duration) that generate the greatest total AQUI-S™ residues in fillet tissue need to be determined. Rainbow trout were exposed to AQUI-S™ in water temperatures of 7, 12, and 17 °C in one of two static exposure regimens: (1) AQUI-S™ concentrations of 14 mg/L (nominal concentration) with an exposure duration of 60 min or (2) AQUI-S™ concentrations of 34 mg/L (nominal concentration) with an exposure duration of 10 min (exposure conditions based on probable U.S. use regimens). Immediately after the end of an exposure, fish were rinsed, sacrificed, and skin-on fillets removed. The fillets were homogenized with dry ice, the homogenate extracted with acetonitrile, and extracts analyzed for isoeugenol (the active ingredient in AQUI-S™) by liquid chromatography with absorbance detection. At common water temperatures, the tissue concentration of isoeugenol in fillet tissue from fish exposed to 14-mg/L AQUI-S™ for 60 min was significantly greater than the isoeugenol concentration in fillet tissue from fish exposed to 34-mg/L AQUI-S™ for 10 min ( P < 0.01). The isoeugenol concentration (78.8 μg/g) found in fillet tissue from fish exposed to 14-mg/L AQUI-S™ for 60 min at 17 °C was significantly greater than the isoeugenol tissue concentration (57.3 μg/g) generated at 7 °C ( P < 0.01), but was not significantly greater than the isoeugenol tissue concentration (70.7 μg/g) generated at 12 °C ( P = 0.22). AQUI-S™ exposure regimens and exposure temperatures can significantly impact drug residue concentrations in fillet tissue.

Aquaculture↗

USGS2003

Safety of Aquaflor (florfenicol, 50% Type A Medicated Article), administered in feed to channel catfish, Ictalurus punctatus

Aquaflor, a feed premix containing the broad spectrum antibacterial agent florfenicol (50% w/w), is being developed for use to control enteric septicemia (ESC) in channel catfish Ictalurus punctatus caused by the gram-negative enterobacterium Edwardsiella ictaluri . The recommended dose of Aquaflor to control ESC is 10 mg/kg body weight (BW)/day for 10 days. The study objective was to determine the safety of Aquaflor administered in feed to channel catfish at doses of 0 (control), 10, 30, and 50 mg/kg BW/day for 20 consecutive days. Parameters evaluated included daily mortality, behavioral (appetite, distribution, flight/fright response), and water chemistry observations, initial and terminal weight measurements, and gross and microscopic pathology. Medicated feed consumption was 67—86% of target with group mean doses of 8.5 mg/kg BW/day, 24.6 mg/kg BW/day, and 34.9 mg/kg BW/day. There were no mortalities or clinically observable changes noted at any of the dose levels tested. Aquaflor-related changes were limited to the food consumption and histopathology data. Although Aquaflor-related decreased feed consumption was noted in the 30 and 50 mg/kg BW/day groups, there were no differences in fish growth among the treatment groups. Aquaflor-related histopathology findings were limited to a histomorphologically evident dose-dependent decrease in hematopoietic/lymphopoietic tissue in the anterior kidneys, posterior kidneys, and spleens of channel catfish.

Toxicologic Pathology↗

USGS2003

Safety of aquaflor (florfenicol, 50% type a medicated article), administered in feed to channel catfish, Ictalurus punctatus

Aquaflor, a feed premix containing the broad spectrum antibacterial agent florfenicol (50% w/w), is being developed for use to control enteric septicemia (ESC) in channel catfish Ictalurus punctatus caused by the gram-negative enterobacterium Edwardsiella ictaluri . The recommended dose of Aquaflor to control ESC is 10 mg/kg body weight (BW)/day for 10 days. The study objective was to determine the safety of Aquaflor administered in feed to channel catfish at doses of 0 (control), 10, 30, and 50 mg/kg BW/day for 20 consecutive days. Parameters evaluated included daily mortality, behavioral (appetite, distribution, flight/fright response), and water chemistry observations, initial and terminal weight measurements, and gross and microscopic pathology. Medicated feed consumption was 67-86% of target with group mean doses of 8.5 mg/kg BW/day, 24.6 mg/kg BW/day, and 34.9 mg/kg BW/day. There were no mortalities or clinically observable changes noted at any of the dose levels tested. Aquaflor-related changes were limited to the food consumption and histopathology data. Although Aquaflor-related decreased feed consumption was noted in the 30 and 50 mg/kg BW/day groups, there were no differences in fish growth among the treatment groups. Aquaflor-related histopathology findings were limited to a histomorphologically evident dose-dependent decrease in hematopoietic/lymphopoietic tissue in the anterior kidneys, posterior kidneys, and spleens of channel catfish.

Toxicologic Pathology↗

USGS2003

Residue depletion of oxytetracycline from fillet tissues of northern pike and walleye

The broad-spectrum antibacterial drug oxytetracycline (OTC) is used in the U.S. to treat certain diseases in salmonids and catfish. This study was conducted to support an extension of the OTC label to include all cool-water fish species cultured at U.S. public aquaculture facilities by satisfying human food safety requirements. Juvenile northern pike ( Esox lucius ; mean weight: 117 g) and walleye ( Stizostedion vitreum ; mean weight: 59 g) were fed OTC-medicated diets near the maximum legal treatment rate (82.7 mg OTC-HCl/kg fish/day for 10 days) and near the lower limit of the water temperature range for most disease outbreaks in these species (14 and 16 °C, respectively). Two trials were conducted simultaneously with northern pike, one using commercially medicated feed and the other using on-site OTC top-coated feed. A third trial was performed with walleye using on-site OTC top-coated feed. Fillet tissues were collected and OTC free base (OTC-base) concentrations were determined by high performance liquid chromatography. The maximum mean OTC-base concentrations in the fillet tissue were 319 ng/g in northern pike (skinless) and 721 ng/g in walleye (skin-on), both well below the current tolerance limit of 2000 ng/g OTC-base. The log-linear loss of OTC-base from the fillet tissues was monophasic, with terminal phase half-lives of 5.9 days in northern pike fed commercial medicated feed, 6.7 days in northern pike fed top-coated feed, and 10.5 days in walleye fed top-coated feed. The data supported a zero withdrawal time in juvenile northern pike and walleye fed OTC at the approved dose level for 10 days at water temperatures down to 14 and 16 °C respectively.

Aquaculture↗

USGS2002

Relatively rapid loss of lampricide residues from fillet tissue of fish after routine treatment

The selective sea lamprey ( Petromyzon marinus ) larvicide 3-trifluoromethyl-4-nitrophenol (TFM) is currently used to control parasitic sea lampreys in tributaries to the Great Lakes basin. The concentration and persistence of TFM and its major metabolite, TFM glucuronide (TFM-glu), was determined in fillet tissue of fish after a typical stream application. Rainbow trout ( Oncorhynchus mykiss ) and channel catfish ( Ictalurus punctatus ) were exposed to a nominal concentration of 12.6 nmol/mL TFM for about 12 h during a sea lamprey control treatment of the Ford River in Michigan. Concentrations of TFM and TFM-glu were greatest in the fillet tissues during the exposure period, with greater residues in channel catfish (wet wt; mean, 6.95 nmol/g TFM; mean, 2.40 nmol/g TFM-glu) than in rainbow trout (wet wt; mean, 1.45 nmol/g TFM; mean, 0.93 nmol/g TFM-glu). After the exposure period, residues in both species decreased by 90−99% within 6−12 h and were less than the quantitation limit (<0.03 nmol/g) within 36 h.

Michigan↗

USGS2002

Liquid chromatographic determination of florfenicol in the plasma of multiple species of fish

A simple method was developed for determining florfenicol concentration in a small volume (250 μl) of plasma from five phylogenetically diverse species of freshwater fish. Florfenicol was isolated from the plasma matrix through C 18 solid-phase extraction and quantified by reversed-phase high-performance liquid chromatography with UV detection. The accuracy (84–104%), precision (%RSD⩽8), and sensitivity (quantitation limit <30 ng/ml) of the method indicate its usefulness for conducting pharmacokinetic studies on a variety of freshwater fish.

Journal of Chromatography B: Analytical Technologi↗

USGS2001

Oxytetracycline depletion from skin-on fillet tissue of coho salmon fed oxytetracycline medicated feed in freshwater at temperatures less than 9°C

Oxytetracycline (OTC) is a broad spectrum antibacterial agent approved in the USA for treating certain bacterial diseases in salmonids cultured in freshwater at temperatures greater than or equal to 9°C. This study was conducted to provide the information necessary to expand the OTC label to include treatment of diseased salmonids cultured in freshwater at temperatures below 9°C. The study was designed to treat juvenile coho salmon ( Oncorhynchus kisutch ) with OTC-medicated feed and determine the depletion of OTC from the skin-on fillet tissue. Oxytetracycline depletion was evaluated in juvenile coho salmon (weight range, 13–62 g) fed OTC-medicated feed at a rate of 88.2 mg OTC/kg body weight/day for 10 days. Pairs of skin-on fillets were taken from individual fish on days 4 and 10 during the treatment phase and on days 1, 4, 8, 14, and 19 during the depletion phase. Water temperatures during the study period ranged from 4.1°C to 8.5°C. The OTC concentrations in medicated feed and skin-on fillets were determined with high-performance liquid chromatography methods. The maximum mean OTC concentration in fillet tissue was 932 ng/g, 1 day after the last treatment and decreased to 32 ng/g 19 days after the last treatment. The log-linear loss of OTC from the fillet tissue was biphasic with a terminal phase half-life of 4.9 days.

Aquaculture↗

USGS2001

Short-duration electrical immobilization of lake trout

Chemical anesthetics induce stress responses, and most leave residues in fish tissues that require a certain withdrawal time before the animal can be released into the environment. Therefore, alternatives are needed in cases when fish must be released immediately, for example, during egg-collecting operations or after implanting elastomer tags. To evaluate pulsed direct current as an alternative method of immobilization, individual lake trout Salvelinus namaycush were electrically immobilized using various pulsed-DC voltage gradients and shock durations. Duration of opercular recovery and narcosis were measured for individual fish. Fish were euthanized 24 h after electrical immobilization and processed for lateral radiograph analysis and assessment of perivertebral hemorrhaging by dissection. Survival of lake trout after electrical immobilization at 0.6 V/cm for 30 or 40 s or 0.8 V/cm for 5 or 15 s was monitored for 81 or 84 d after immobilization. Mean narcosis duration increased with voltage gradient and shock duration. Larger fish had longer periods of narcosis at the same combination of voltage gradient and shock duration. Radiological evaluation indicated that 9 of 28 fish in the oldest age-class tested had detectable injuries of the vertebral column, but all but one were in the lowest injury category. Although vertebral column injuries were observed in most small fish, the majority of vertebral column injuries were minor compressions involving two to seven vertebrae. Of the 82 lake trout electrically immobilized to assess long-term survival, only 5 died (6%). Our data suggest that lake trout could be electrically immobilized for a sufficient period to allow field workers to collect length and weight data and implant visible implant tags or colored elastomer tags. The technique we used, however, is probably not appropriate for procedures that require immobilization for more than 2–3 min.

North American Journal of Fisheries Management↗

USGS1982

Acute and chronic toxicity studies with monochlorobenzene in rainbow trout

The toxicity of monochlorobenzene (CB) was investigated in rainbow trout following acute intraperitoneal (i.p.) administration and chronic exposure via the water in a continuously flowing system for 15 or 30 days. In the acute study overt toxicity and hepatotoxicity were monitored over a 96-h time period. Variables measured to assess toxicity included weight changes, liver weight to body weight ratios, behavioral changes, alanine aminotransferase activity (GPT), sulfobromophthalein (BSP) retention, total plasma protein concentration and liver histopathology. In the chronic study the same measures of toxicity were followed as well as food consumption and alkaline phosphatase (AP) activity. Upon acute i.p. exposure the toxicant (9.8 mmol/kg) caused behavioral changes in the fish which were consistent with the known anesthetic properties of CB in mammals. Elevations in BSP retention and GPT activity, and histopathology indicated that CB was hepatotoxic in fish. The LC 50 of CB in trout exposed via the water for 96 h was 4.7 mg/l. Chronic exposure of trout to 2 or 3 mg/l CB resulted in similar behavioral changes as seen in the acute study. Liver toxicity was evident from elevations in GPT activity. BSP retention and AP activity appeared to be affected by the nutritional status of the trout as much as by the CB treatment. After 30 days of exposure to 3 mg/l CB, trout appeared to have developed some tolerance to the toxic effects.

Aquatic Toxicology↗